A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
Public ClinicalTrials.gov record NCT06395753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Open-Label, Dose-Finding Study of Debio 4228, an Extended-Release Formulation of Gonadotropin-Releasing Hormone Antagonist in Participants With Advanced Prostate Cancer
Study identification
- NCT ID
- NCT06395753
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Debiopharm International SA
- Industry
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Interventions
- Debio 4228 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2024
- Primary completion
- Nov 30, 2026
- Completion
- Dec 31, 2026
- Last update posted
- Apr 27, 2026
2024 – 2027
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Urologic Surgeons of Arizona | Mesa | Arizona | 85206 | — |
| East Valley Urology Center of Arizona | Queen Creek | Arizona | 85140 | — |
| Bakersfield Institute of Advanced Urology | Bakersfield | California | 93301 | — |
| Grimaldi Urology | Chula Vista | California | 91910 | — |
| Valley Urology | Fresno | California | 93722 | — |
| Tower Urology, | Los Angeles | California | 90048 | — |
| Alarcon Urology Center | Montebello | California | 90640 | — |
| Urology Center of Southern California | Murrieta | California | 92563 | — |
| AP Medical Research | Miami | Florida | 33165 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Oregon Urology Institut | Springfield | Oregon | 97477 | — |
| Carolina Urologic Research Center | Myrtle Beach | South Carolina | 29572 | — |
| Urology of Virginia | Virginia Beach | Virginia | 23462 | — |
| Summit Cancer Centers of North Spokane | Spokane | Washington | 99208 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06395753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 27, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06395753 live on ClinicalTrials.gov.